Department of Life Sciences, Health Biotechnology Program - King Fahad Chair for Health Biotechnology, College of Graduate Studies, Arabian Gulf University, Manama, Bahrain.
Department of Family and Community Medicine, College of Medicine and Medical Sciences, Arabian Gulf University, Manama, Bahrain.
Front Cell Infect Microbiol. 2022 Aug 10;12:868205. doi: 10.3389/fcimb.2022.868205. eCollection 2022.
In this study, we evaluated the use of a predictive computational approach for SARS-CoV-2 genetic variations analysis in improving the current variant labeling system. First, we reviewed the basis of the system developed by the World Health Organization (WHO) for the labeling of SARS-CoV-2 genetic variants and the derivative adapted by the United States Centers for Disease Control and Prevention (CDC). Both labeling systems are based on the virus' major attributes. However, we found that the labeling criteria of the SARS-CoV-2 variants derived from these attributes are not accurately defined and are used differently by the two agencies. Consequently, discrepancies exist between the labels given by WHO and the CDC to the same variants. Our observations suggest that giving the variant of concern (VOC) label to a new variant is premature and might not be appropriate. Therefore, we used a comparative computational approach to predict the effects of the mutations on the virus structure and functions of five VOCs. By linking these data to the criteria used by WHO/CDC for variant labeling, we ascertained that a predictive computational comparative approach of the genetic variations is a good way for rapid and more accurate labeling of SARS-CoV-2 variants. We propose to label all emergent variants, variant under monitoring or variant being monitored (VUM/VBM), and to carry out computational predictive studies with thorough comparison to existing variants, upon which more appropriate and informative labels can be attributed. Furthermore, harmonization of the variant labeling system would be globally beneficial to communicate about and fight the COVID-19 pandemic.
在这项研究中,我们评估了使用预测计算方法分析 SARS-CoV-2 遗传变异以改进当前变异标签系统的效果。首先,我们回顾了世界卫生组织(WHO)开发的用于标记 SARS-CoV-2 遗传变异的系统以及美国疾病控制与预防中心(CDC)改编的衍生系统的基础。这两个标签系统都基于病毒的主要属性。然而,我们发现,这些属性衍生出的 SARS-CoV-2 变异的标签标准没有明确定义,而且这两个机构的使用方式也不同。因此,WHO 和 CDC 对同一变异体的标签存在差异。我们的观察表明,过早地给新变异体贴上关切变异体(VOC)的标签可能并不合适。因此,我们使用了比较计算方法来预测五种 VOC 突变对病毒结构和功能的影响。通过将这些数据与 WHO/CDC 用于变异体标签的标准联系起来,我们确定了遗传变异的预测计算比较方法是一种快速、更准确地标记 SARS-CoV-2 变异体的好方法。我们建议对所有新出现的变异体、监测中的变异体或正在监测的变异体(VUM/VBM)进行标签,并对其进行计算预测研究,与现有变异体进行彻底比较,以便给出更合适和有意义的标签。此外,变异体标签系统的协调统一将有利于全球范围内就 COVID-19 大流行进行沟通和应对。